Essential elements of the capsid protein for self-assembly into empty virus-like particles of hepatitis E virus

Tian Cheng Li, Naokazu Takeda, Tatsuo Miyamura, Yoshiharu Matsuura, Joseph C Y Wang, Helena Engvall, Lena Hammar, Li Xing, R. Holland Cheng

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Hepatitis E virus (HEV) is a noncultivable virus that causes acute liver failure in humans. The virus's major capsid protein is encoded by an open reading frame 2 (ORF2) gene. When the recombinant protein consisting of amino acid (aa) residues 112 to 660 of ORF2 is expressed with a recombinant baculovirus, the protein self-assembles into virus-like particles (VLPs) (T.-C. Li, Y. Yamakawa, K. Suzuki, M. Tatsumi, M. A. Razak, T. Uchida, N. Takeda, and T. Miyamura, J. Virol. 71:7207-7213, 1997). VLPs can be found in the culture medium of infected Tn5 cells but not in that of Sf9 cells, and the major VLPs have lost the C-terminal 52 aa. To investigate the protein requirement for HEV VLP formation, we prepared 14 baculovirus recombinants to express the capsid proteins truncated at the N terminus, the C terminus, or both. The capsid protein consisting of aa residues 112 to 608 formed VLPs in Sf9 cells, suggesting that particle formation is dependent on the modification process of the ORF2 protein. In the present study, electron cryomicroscopy and image processing of VLPs produced in Sf9 and Tn5 cells indicated that they possess the same configurations and structures. Empty VLPs were found in both Tn5 and Sf9 cells infected with the recombinant containing an N-terminal truncation up to aa residue 125 and C-terminal to aa residue 601, demonstrating that the aa residues 126 to 601 are the essential elements required for the initiation of VLP assembly. The recombinant HEV VLPs are potential mucosal vaccine carrier vehicles for the presentation of foreign antigenic epitopes and may also serve as vectors for the delivery of genes to mucosal tissue for DNA vaccination and gene therapy. The results of the present study provide useful information for constructing recombinant HEV VLPs having novel functions.

Original languageEnglish (US)
Pages (from-to)12999-13006
Number of pages8
JournalJournal of Virology
Volume79
Issue number20
DOIs
StatePublished - Oct 2005

Fingerprint

Hepatitis E virus
virus-like particles
Capsid Proteins
coat proteins
Virion
Sf9 Cells
Amino Acids
amino acids
Open Reading Frames
open reading frames
Baculoviridae
Recombinant Proteins
Genetic Therapy
cells
Viruses
Cryoelectron Microscopy
liver failure
viruses
gene therapy
Acute Liver Failure

ASJC Scopus subject areas

  • Immunology

Cite this

Li, T. C., Takeda, N., Miyamura, T., Matsuura, Y., Wang, J. C. Y., Engvall, H., ... Cheng, R. H. (2005). Essential elements of the capsid protein for self-assembly into empty virus-like particles of hepatitis E virus. Journal of Virology, 79(20), 12999-13006. https://doi.org/10.1128/JVI.79.20.12999-13006.2005

Essential elements of the capsid protein for self-assembly into empty virus-like particles of hepatitis E virus. / Li, Tian Cheng; Takeda, Naokazu; Miyamura, Tatsuo; Matsuura, Yoshiharu; Wang, Joseph C Y; Engvall, Helena; Hammar, Lena; Xing, Li; Cheng, R. Holland.

In: Journal of Virology, Vol. 79, No. 20, 10.2005, p. 12999-13006.

Research output: Contribution to journalArticle

Li, TC, Takeda, N, Miyamura, T, Matsuura, Y, Wang, JCY, Engvall, H, Hammar, L, Xing, L & Cheng, RH 2005, 'Essential elements of the capsid protein for self-assembly into empty virus-like particles of hepatitis E virus', Journal of Virology, vol. 79, no. 20, pp. 12999-13006. https://doi.org/10.1128/JVI.79.20.12999-13006.2005
Li, Tian Cheng ; Takeda, Naokazu ; Miyamura, Tatsuo ; Matsuura, Yoshiharu ; Wang, Joseph C Y ; Engvall, Helena ; Hammar, Lena ; Xing, Li ; Cheng, R. Holland. / Essential elements of the capsid protein for self-assembly into empty virus-like particles of hepatitis E virus. In: Journal of Virology. 2005 ; Vol. 79, No. 20. pp. 12999-13006.
@article{5dda75e37ffa49738743494c25db790a,
title = "Essential elements of the capsid protein for self-assembly into empty virus-like particles of hepatitis E virus",
abstract = "Hepatitis E virus (HEV) is a noncultivable virus that causes acute liver failure in humans. The virus's major capsid protein is encoded by an open reading frame 2 (ORF2) gene. When the recombinant protein consisting of amino acid (aa) residues 112 to 660 of ORF2 is expressed with a recombinant baculovirus, the protein self-assembles into virus-like particles (VLPs) (T.-C. Li, Y. Yamakawa, K. Suzuki, M. Tatsumi, M. A. Razak, T. Uchida, N. Takeda, and T. Miyamura, J. Virol. 71:7207-7213, 1997). VLPs can be found in the culture medium of infected Tn5 cells but not in that of Sf9 cells, and the major VLPs have lost the C-terminal 52 aa. To investigate the protein requirement for HEV VLP formation, we prepared 14 baculovirus recombinants to express the capsid proteins truncated at the N terminus, the C terminus, or both. The capsid protein consisting of aa residues 112 to 608 formed VLPs in Sf9 cells, suggesting that particle formation is dependent on the modification process of the ORF2 protein. In the present study, electron cryomicroscopy and image processing of VLPs produced in Sf9 and Tn5 cells indicated that they possess the same configurations and structures. Empty VLPs were found in both Tn5 and Sf9 cells infected with the recombinant containing an N-terminal truncation up to aa residue 125 and C-terminal to aa residue 601, demonstrating that the aa residues 126 to 601 are the essential elements required for the initiation of VLP assembly. The recombinant HEV VLPs are potential mucosal vaccine carrier vehicles for the presentation of foreign antigenic epitopes and may also serve as vectors for the delivery of genes to mucosal tissue for DNA vaccination and gene therapy. The results of the present study provide useful information for constructing recombinant HEV VLPs having novel functions.",
author = "Li, {Tian Cheng} and Naokazu Takeda and Tatsuo Miyamura and Yoshiharu Matsuura and Wang, {Joseph C Y} and Helena Engvall and Lena Hammar and Li Xing and Cheng, {R. Holland}",
year = "2005",
month = "10",
doi = "10.1128/JVI.79.20.12999-13006.2005",
language = "English (US)",
volume = "79",
pages = "12999--13006",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "20",

}

TY - JOUR

T1 - Essential elements of the capsid protein for self-assembly into empty virus-like particles of hepatitis E virus

AU - Li, Tian Cheng

AU - Takeda, Naokazu

AU - Miyamura, Tatsuo

AU - Matsuura, Yoshiharu

AU - Wang, Joseph C Y

AU - Engvall, Helena

AU - Hammar, Lena

AU - Xing, Li

AU - Cheng, R. Holland

PY - 2005/10

Y1 - 2005/10

N2 - Hepatitis E virus (HEV) is a noncultivable virus that causes acute liver failure in humans. The virus's major capsid protein is encoded by an open reading frame 2 (ORF2) gene. When the recombinant protein consisting of amino acid (aa) residues 112 to 660 of ORF2 is expressed with a recombinant baculovirus, the protein self-assembles into virus-like particles (VLPs) (T.-C. Li, Y. Yamakawa, K. Suzuki, M. Tatsumi, M. A. Razak, T. Uchida, N. Takeda, and T. Miyamura, J. Virol. 71:7207-7213, 1997). VLPs can be found in the culture medium of infected Tn5 cells but not in that of Sf9 cells, and the major VLPs have lost the C-terminal 52 aa. To investigate the protein requirement for HEV VLP formation, we prepared 14 baculovirus recombinants to express the capsid proteins truncated at the N terminus, the C terminus, or both. The capsid protein consisting of aa residues 112 to 608 formed VLPs in Sf9 cells, suggesting that particle formation is dependent on the modification process of the ORF2 protein. In the present study, electron cryomicroscopy and image processing of VLPs produced in Sf9 and Tn5 cells indicated that they possess the same configurations and structures. Empty VLPs were found in both Tn5 and Sf9 cells infected with the recombinant containing an N-terminal truncation up to aa residue 125 and C-terminal to aa residue 601, demonstrating that the aa residues 126 to 601 are the essential elements required for the initiation of VLP assembly. The recombinant HEV VLPs are potential mucosal vaccine carrier vehicles for the presentation of foreign antigenic epitopes and may also serve as vectors for the delivery of genes to mucosal tissue for DNA vaccination and gene therapy. The results of the present study provide useful information for constructing recombinant HEV VLPs having novel functions.

AB - Hepatitis E virus (HEV) is a noncultivable virus that causes acute liver failure in humans. The virus's major capsid protein is encoded by an open reading frame 2 (ORF2) gene. When the recombinant protein consisting of amino acid (aa) residues 112 to 660 of ORF2 is expressed with a recombinant baculovirus, the protein self-assembles into virus-like particles (VLPs) (T.-C. Li, Y. Yamakawa, K. Suzuki, M. Tatsumi, M. A. Razak, T. Uchida, N. Takeda, and T. Miyamura, J. Virol. 71:7207-7213, 1997). VLPs can be found in the culture medium of infected Tn5 cells but not in that of Sf9 cells, and the major VLPs have lost the C-terminal 52 aa. To investigate the protein requirement for HEV VLP formation, we prepared 14 baculovirus recombinants to express the capsid proteins truncated at the N terminus, the C terminus, or both. The capsid protein consisting of aa residues 112 to 608 formed VLPs in Sf9 cells, suggesting that particle formation is dependent on the modification process of the ORF2 protein. In the present study, electron cryomicroscopy and image processing of VLPs produced in Sf9 and Tn5 cells indicated that they possess the same configurations and structures. Empty VLPs were found in both Tn5 and Sf9 cells infected with the recombinant containing an N-terminal truncation up to aa residue 125 and C-terminal to aa residue 601, demonstrating that the aa residues 126 to 601 are the essential elements required for the initiation of VLP assembly. The recombinant HEV VLPs are potential mucosal vaccine carrier vehicles for the presentation of foreign antigenic epitopes and may also serve as vectors for the delivery of genes to mucosal tissue for DNA vaccination and gene therapy. The results of the present study provide useful information for constructing recombinant HEV VLPs having novel functions.

UR - http://www.scopus.com/inward/record.url?scp=26444507185&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=26444507185&partnerID=8YFLogxK

U2 - 10.1128/JVI.79.20.12999-13006.2005

DO - 10.1128/JVI.79.20.12999-13006.2005

M3 - Article

C2 - 16189002

AN - SCOPUS:26444507185

VL - 79

SP - 12999

EP - 13006

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 20

ER -